Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-15-000037
Filing Date
2015-05-07
Accepted
2015-05-07 17:19:16
Documents
1
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_143103354078712.html 4  
1 FORM 4 wf-form4_143103354078712.xml 4 3090
  Complete submission text file 0001274644-15-000037.txt   4591
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 15843029